REFERENCES
- Gibbons R V, Vaughn D W. Dengue: an escalating problem. BMJ 2002; 324: 1563–6, [INFOTRIEVE], [CSA]
- Gubler D J. Epidemic dengue/dengue hemorrhagic fever as a public health, social andeconomic problem in the 21st century. Trends Microbiol 2002; 10: 100–3, [INFOTRIEVE], [CROSSREF], [CSA]
- Lindback H, Lindback J, Tegnell A, Janzon R, Vene S, Ekdahl K. Dengue fever in travelers to the tropics, 1998 and1999. Emerg Infect Dis 2003; 9: 438–42, [INFOTRIEVE], [CSA]
- Gubler D J, Clark G G. Dengue/dengue hemorragic fever: the emergence of a global health problem. Emerg Infect Dis 1995; 1: 55–7, [INFOTRIEVE], [CSA]
- World Health Organization. Dengue/dengue haemorragic fever: situation in 2000. Wkly Epidemiol Rec 2000; 75: 193–200, [CSA]
- Potasman I, Srugo I, Schwartz E. Dengue seroconversion among Israeli travelers to tropical countries. Emerg Infect Dis 1999; 5: 824–7, [INFOTRIEVE], [CSA]
- Jelinek T. Dengue fever in international travelers. Clin Infect Dis 2000; 31: 144–7, [INFOTRIEVE], [CROSSREF], [CSA]
- Sharp T W, Wallace M R, Hayes C G, et al. Dengue fever in U.S. troops during operation Restore Hope, Somalia, 1992–1993. Am J Trop Med Hyg 1995; 53: 89–94, [INFOTRIEVE], [CSA]
- Trofa A F, DeFraites R F, Smoak B L, et al. Dengue fever in US military personnel in Haiti. JAMA 1997; 277: 1546–8, [INFOTRIEVE], [CROSSREF], [CSA]
- Siler J F, Hall M W, Hitchens A P. Dengue, its history, epidemiology, mechanism of transmission, etiology, clinical manifestations, immunity, andprevention. Philippine J Sci 1926; 29: 1–302, [CSA]
- Sabin A B. Research on dengue during World War II. Am J Trop Med Hyg 1952; 1: 30–2, [INFOTRIEVE], [CSA]
- Deller J J, Jr, Russell P K. An analysis of fevers of unknown origin in American soldiers in Vietnam. Ann Intern Med 1967; 66: 1129–43, [INFOTRIEVE], [CSA]
- Kanesa-thasan N, Iacono-Connors L, Magill A, et al. Dengue serotypes 2 and3 in US forces in Somalia [letter]. Lancet 1994; 343: 678, [INFOTRIEVE], [CROSSREF], [CSA]
- Edelman R. Dengue anddengue vaccines. J Infect Dis 2005; 191: 650–3, [INFOTRIEVE], [CROSSREF], [CSA]
- Innis B L, Eckels K H. Progress in development of a live-attenuated, tetravalent dengue virus vaccine by the United States Army Medical Research andMateriel Command. Am J Trop Med Hyg 2003; 69(6 suppl)1–4, [INFOTRIEVE], [CSA]
- Eckels K H, Brandt W E, Harrison V R, McCown J M, Russell P K. Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect Immun 1976; 14: 1221–7, [INFOTRIEVE], [CSA]
- Eckels K H, Harrison V R, Summers P L, Russell P K. Dengue-2 vaccine: preparation from a small-plaque virus clone. Infect Immun 1980; 27: 175–80, [INFOTRIEVE], [CSA]
- Bancroft W H, Top F H, Eckels K H, Anderson J H, McCown J M, Russell P K. Dengue-2 vaccine: virological, immunological, andclinical responses of six yellow fever-immune recipients. Infect Immun 1981; 31: 698–703, [INFOTRIEVE], [CSA]
- Scott R M, Eckels K H, Bancroft W H, et al. Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status. J Infect Dis 1984; 148: 1055–60, [CSA]
- Bancroft W H, Scott R M, Eckels K H, et al. Dengue virus type 2 vaccine: reactogenicity andimmunogenicity in soldiers. J Infect Dis 1984; 149: 1005–10, [INFOTRIEVE], [CSA]
- Eckels K H, Scott R M, Bancroft W H, et al. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells. Am J Trop Med Hyg 1984; 33: 684–9, [INFOTRIEVE], [CSA]
- McKee K T, Jr, Bancroft W H, Eckels K H, Redfield R R, Summers P L, Russell P K. Lack of attenuation of a candidate dengue 1 vaccine (45AZ5) in human volunteers. Am J Trop Med Hyg 1987; 36: 435–42, [INFOTRIEVE], [CSA]
- Innis B L, Eckels K H, Kraiselburd E, et al. Virulence of a live dengue virus vaccine candidate: A possible new marker of dengue virus attenuation. J Infect Dis 1998; 158: 876–80, [CSA]
- Sabin A B, Schlesinger R W. Production of immunity to dengue with virus modified by propagation in mice. Science 1945; 101: 640–2, [CSA]
- Wisseman C L, Jr, Sweet B H, Rosenzweig E C, Eylar O R. Attenuated living type 1 dengue vaccines. Am J Trop Med Hyg 1963; 12: 620–3, [CSA]
- Ratageri V H, Shepur T A, Wari P K, Chavan S C, Mujahid I B, Yergolkar P N. Clinical profile andoutcome of dengue fever cases. Indian J Pediatr 2005; 72: 705–6, [INFOTRIEVE], [CSA]
- World Health Organization. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention andControl, 2nd ed. World Health Organization, GenevaSwitzerland 1997
- World Health Organization. WHO report on global surveillance of epidemic prone infectious diseases, Available at: http://www/who.int/emc.doctments/surveillance/docs/whocdscsrisr2001.html. Accessed December 2005
- Taylor S F, Patel P R, Herold T JS. Recurrent arthralgias in a patient with previous mayaro fever infection. South Med J 2005; 98: 484–6, [INFOTRIEVE], [CROSSREF], [CSA]
- Taylor S F. Viral mosquito-borne febrile arthritides. J Special Operations Med 2004; 4(2)28–31, [CSA]
- McGill P E. Viral infections: alpha-viral arthropathy. Baillieres Clin Rheumatol 1995; 9: 145–50, [INFOTRIEVE], [CROSSREF], [CSA]
- Tesh R B. Arthritides caused by mospuite-borne viruses. Annu Rev Med 1982; 33: 31–40, [INFOTRIEVE], [CROSSREF], [CSA]
- McBride W J. Deaths associated with dengue haemorrhagic fever: the first in Australia in over a century. Med J Aust 2005; 183: 35–7, [INFOTRIEVE], [CSA]
- Public Health andPreventive Medicine. Viruses causing undifferentiated febrile illness, 13th ed. Appleton andLange, Stamford, CT 1992; 224–5
- Peragallo M S, Nicoletti L, Lista F, D'Amelio R D. Probable Dengue virus infection among Italian troops, East Timor, 1999–2000. Emerg Infect Dis 2003; 9: 876–80, [INFOTRIEVE], [CSA]
- Halstead S B. Observations related to pathogenesis of dengue hemorrhagic fever: hypotheses anddiscussion. Yale J Biol Med 1970; 42: 350–62, [INFOTRIEVE], [CSA]
- Halstead S B. The pathogenesis of dengue: molecular epidemiology in infectious disease. Am J Epidemiol 1981; 114: 632–48, [INFOTRIEVE], [CSA]
- Barnes W JS, Rosen L. Fatal hemorrhagic disease andshock associated with primary dengue infection on a Pacific Island. Am J Trop Med Hyg 1974; 23: 495–506, [INFOTRIEVE], [CSA]
- Public Health andPreventive Medicine. Viruses causing hemorrhagic fever, 13th ed. Appleton andLange, Stamford, CT 1992; 225–8
- Teixeira M D, Costa M D, Barreto M L, Mota E. Dengue anddengue hemorrhagic fever epidemics in Brazil: what research is needed based on trends, surveillance, andcontrol experiences?. Cad Saude Publica 2005; 21: 1307–15, [CSA]
- Lutz R H, Carlton D, Taylor S F. HIV Postexposure prophylaxis in the remote prehospital environment. Prehosp Emerg Med 2002; 6: 2320–35, [CSA]
- Lee I K, Liu J W, Yang K D. Clinical characteristics andrisk factors for concurrent bacteremia in adults with dengue hemorrhagic Fever. Am J Trop Med Hyg 2005; 72: 221–6, [INFOTRIEVE], [CSA]
- Carlini M E, Shandera W X. Infectious diseases: viral andrickettsial. Current Medical Diagnosis & Treatment, 40th ed. Appleton & Lange, Stamford, CT 2001; 1330–1
- Gren J, Velzing J, Copra C, et al. Diagnostic value of dengue virus-specific IgA andIgM serum antibody detection. Microbes Infect 1999; 13: 1085–90, [CROSSREF], [CSA]
- Vaughn D, Green S. Dengue anddengue hemorrhagic fever. Hunter's Tropical Medicine andEmerging Infectious Diseases. 8th ed., G Strickland. Saunders, Philadelphia, PA 2000; 240–5
- Tsai T. Yellow fever, dengue, dengue hemmorhagic fever, Japanese encephalitis, St. Louis encephalitis, tick-born encephalitis. Principles andPractices of Infectious Diseases. 5th ed., G Mandell, J Bennett, R Dolin. Churchill Livingstone, New York, NY 2000; 1714–31
- Pagana K, Pagana T. Flaviviruses. Mosby's Manual of Diagnostic andLaboratory Tests. Mosby, Philadelphia, PA 1998
- Halstead S. Dengue fever/dengue hemorrahagic fever. Nelson Textbook of Pediatrics. 16th ed., W E Nelson, R E Behrman, R M Kliegman, A M Arvin. Saunders, Philadelphia, PA 2000; 1005–8
- World Health Organization. World Health Organization, GenevaSwitzerland 1998, The World Report, 1998
- Ngo N T, Cao X T, Kneen R, et al. Acute management of dengue shock syndrome: a randomized double-blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 2001; 32: 204–13, [INFOTRIEVE], [CROSSREF], [CSA]
- Kneen R, Hien T T, White N J, Farrar J J. Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluidregimens. Clin Infect Dis 1999; 29: 787–94, [INFOTRIEVE], [CSA]
- Chuansumrit A, Phimolthares V, Tardtong P, Tapaneya-Olam W, Kowsathit P, Chantarojsiri T. Transfusion requirements in patients with dengue hemorrhagic fever. Southeast Asian J Trop Med Public Health 2000; 31: 10–14, [INFOTRIEVE], [CSA]
- Dung N M, Day N P, Tam D T, et al. Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens. Clin Infect Dis 1999; 29: 787–94, [INFOTRIEVE], [CSA]
- Ericsson C, Steffen R. Dengue fever in international travelers. Clin Infect Dis 2005; 31: 144–7, [CSA]
- Taylor S F, Kopchinski B, Schreiber M A, Singleton L. Trauma patient outcome in an Army deployable medical systems environment compared with a medical center. Mil Med 2000; 165: 867–9, [INFOTRIEVE], [CSA]
- Taylor S F, Lutz R H, Millward J A. Disease andnonbattle injury related to peacekeeping operations in South America: summary patient care statistics for CABANAS 2000. Mil Med 2001; 166: 1059–61, [INFOTRIEVE], [CSA]
- Taylor S F, Lutz R H, Millward J A. Primary, acute, andemergency care considerations related to peace keeping operations in South America. South Med J 2001; 94: S24–S25, [CSA]
- Taylor S F, Gerhardt R T. Prehospital ground andair EMS of the Argentine Special Forces andParatroopers. Prehosp Emerg Care 2002; 6: 174, [CSA]